Literature DB >> 21092109

Radiological and pathological findings of a metastatic composite paraganglioma with neuroblastoma in a man: a case report.

Florian R Fritzsche1, Peter K Bode, Sonja Koch, Thomas Frauenfelder.   

Abstract

INTRODUCTION: Composite tumors of the adrenal medulla or paraganglia are extremely rare and present a diagnostic dilemma. These tumors consist of a neuroendocrine component mixed with a neural component.We describe the imaging characteristics together with the corresponding pathological findings of a composite tumor. Apart from any component-specific imaging findings, the hallmark of this entity is the presence of histologically distinguishable components. CASE
PRESENTATION: A 61-year-old Caucasian man was referred to our hospital due to a suspect lesion found on chest computed tomography carried out for unclear thoracic pain. An abdominal computed tomography scan and ultrasound examination detected a retroperitoneal tumor comprising two different tumor components. Twenty-four-hour urine revealed high levels of normetanephrine, characteristic of a neuroendocrine tumor. An octreoscan prior to surgical procedures revealed multiple osseous and intra-hepatic metastases. The final histopathological workup revealed a composite paraganglioma with neuroblastoma. Our patient died ten months after the initial diagnosis from tumor-associated complications.
CONCLUSIONS: Composite paragangliomas with neuroblastoma are rare tumors of the retroperitoneum. Such tumors should be considered in the differential diagnosis of retroperitoneal masses.

Entities:  

Year:  2010        PMID: 21092109      PMCID: PMC2997098          DOI: 10.1186/1752-1947-4-374

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  10 in total

1.  Composite paraganglioma-ganglioneuroma in the retroperitoneum.

Authors:  Shoji Hirasaki; Hiromitsu Kanzaki; Masato Okuda; Seiyuu Suzuki; Tetsuji Fukuhara; Toshihito Hanaoka
Journal:  World J Surg Oncol       Date:  2009-11-05       Impact factor: 2.754

2.  Sporadic type composite pheochromocytoma with neuroblastoma: clinicomorphologic, DNA content and ret gene analysis.

Authors:  F A Candanedo-González; I Alvarado-Cabrero; A Gamboa-Domínguez; A Cérbulo-Vázquez; R López-Romero; L Bornstein-Quevedo; M Salcedo-Vargas
Journal:  Endocr Pathol       Date:  2001       Impact factor: 3.943

3.  False positive test results for pheochromocytoma from 2000 to 2008.

Authors:  R Yu; M Wei
Journal:  Exp Clin Endocrinol Diabetes       Date:  2009-12-08       Impact factor: 2.949

4.  Clinical spectrum and outcome of functional extraadrenal paraganglioma.

Authors:  D S O'Riordain; W F Young; C S Grant; J A Carney; J A van Heerden
Journal:  World J Surg       Date:  1996-09       Impact factor: 3.352

5.  Spectrum of CT findings in nonmalignant disease of the adrenal gland.

Authors:  A Kawashima; C M Sandler; E K Fishman; C Charnsangavej; K Yasumori; H Honda; R D Ernst; N Takahashi; B K Raval; K Masuda; S M Goldman
Journal:  Radiographics       Date:  1998 Mar-Apr       Impact factor: 5.333

Review 6.  Neurogenic tumors in the abdomen: tumor types and imaging characteristics.

Authors:  Sung Eun Rha; Jae Young Byun; Seung Eun Jung; Ho Jong Chun; Hae Giu Lee; Jae Mun Lee
Journal:  Radiographics       Date:  2003 Jan-Feb       Impact factor: 5.333

7.  Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease.

Authors:  H P Neumann; D P Berger; G Sigmund; U Blum; D Schmidt; R J Parmer; B Volk; G Kirste
Journal:  N Engl J Med       Date:  1993-11-18       Impact factor: 91.245

8.  Composite pheochromocytoma: a clinicopathologic and molecular comparison with ordinary pheochromocytoma and neuroblastoma.

Authors:  Jessica M Comstock; Carlynn Willmore-Payne; Joseph A Holden; Cheryl M Coffin
Journal:  Am J Clin Pathol       Date:  2009-07       Impact factor: 2.493

9.  Composite Pheochromocytoma-Ganglioneuroma of the Adrenal Gland: An Uncommon Entity with Distinctive Clinicopathologic Features.

Authors:  King-Yin Lam; Chung-Yau Lo
Journal:  Endocr Pathol       Date:  1999       Impact factor: 3.943

10.  Succinate dehydrogenase subunit B (SDHB) gene deletion associated with a composite paraganglioma/neuroblastoma.

Authors:  R Armstrong; K L Greenhalgh; E Rattenberry; B Judd; R Shukla; P D Losty; E R Maher
Journal:  J Med Genet       Date:  2009-03       Impact factor: 6.318

  10 in total
  6 in total

1.  Composite Paraganglioma and Neuroblastoma of the Urinary Bladder: A Rare Histopathological Entity.

Authors:  Evan Lacefield; Omer A Raheem; Roni Cox; Rodney Davis; Mohamed H Kamel
Journal:  Curr Urol       Date:  2015-11-10

Review 2.  Update on Adrenal Tumours in 2017 World Health Organization (WHO) of Endocrine Tumours.

Authors:  Alfred King-Yin Lam
Journal:  Endocr Pathol       Date:  2017-09       Impact factor: 3.943

3.  Imaging findings of malignant bilateral carotid body tumors: A case report and review of the literature.

Authors:  Han Lv; Xiaohong Chen; Shuai Zhou; Suping Cui; Yunlong Bai; Zhenchang Wang
Journal:  Oncol Lett       Date:  2016-02-15       Impact factor: 2.967

4.  [Malignant paraganglioma of the orbit, a case report].

Authors:  Idriss Benatiya Andaloussi; Mustapha Maaroufi; Mohammed Benzagmout; Taoufiq Harmouch; Meryem Abdellaoui; Salima Bhallil; Siham Tizniti; Mohammed Chaoui Elfaiz; Afaf Amarti; Hicham Tahri
Journal:  Pan Afr Med J       Date:  2012-06-21

5.  Delayed intracranial and bony metastasis of paraganglioma.

Authors:  Andrew Yew; Won Kim; Sue Chang; Isaac Yang
Journal:  Surg Neurol Int       Date:  2011-05-14

6.  Expression of Extracellular Signal-regulated Kinase 5 and Ankyrin Repeat Domain 1 in Composite Pheochromocytoma and Ganglioneuroblastoma Detected Incidentally in the Adult Adrenal Gland.

Authors:  Shinta Suenaga; Osamu Ichiyanagi; Hiromi Ito; Sei Naito; Tomoyuki Kato; Akira Nagaoka; Tomoya Kato; Mitsunori Yamakawa; Yutaro Obara; Norihiko Tsuchiya
Journal:  Intern Med       Date:  2016-12-15       Impact factor: 1.271

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.